Multi-scale predictions of drug resistance epidemiology suggest a new design principle for rational drug design.
S. Leighow, C. Liu, H. Inam, B. Zhao, J. R. Pritchard
This paper identifies a new principle in drug resistance where the most likely mutations, not the most resistant ones, dominate clinical outcomes, suggesting a strategy to minimize resistance through drug design.
bioRxiv · Sep 19, 2019 · PreprintEvolutionary Biology